ES8708229A1 - Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas. - Google Patents

Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.

Info

Publication number
ES8708229A1
ES8708229A1 ES554336A ES554336A ES8708229A1 ES 8708229 A1 ES8708229 A1 ES 8708229A1 ES 554336 A ES554336 A ES 554336A ES 554336 A ES554336 A ES 554336A ES 8708229 A1 ES8708229 A1 ES 8708229A1
Authority
ES
Spain
Prior art keywords
quinolin
imidazo
dihydro
onas
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554336A
Other languages
English (en)
Spanish (es)
Other versions
ES554336A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES554336A0 publication Critical patent/ES554336A0/es
Publication of ES8708229A1 publication Critical patent/ES8708229A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES554336A 1985-04-25 1986-04-24 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas. Expired ES8708229A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (2)

Publication Number Publication Date
ES554336A0 ES554336A0 (es) 1987-10-01
ES8708229A1 true ES8708229A1 (es) 1987-10-01

Family

ID=27111398

Family Applications (3)

Application Number Title Priority Date Filing Date
ES554336A Expired ES8708229A1 (es) 1985-04-25 1986-04-24 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.
ES557552A Expired ES8802521A1 (es) 1985-04-25 1987-05-14 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
ES557551A Expired ES8801829A1 (es) 1985-04-25 1987-05-14 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557552A Expired ES8802521A1 (es) 1985-04-25 1987-05-14 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas
ES557551A Expired ES8801829A1 (es) 1985-04-25 1987-05-14 Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas

Country Status (32)

Country Link
US (1) US4668686A (OSRAM)
KR (1) KR940000828B1 (OSRAM)
CN (1) CN1016175B (OSRAM)
AT (1) AT390257B (OSRAM)
AU (1) AU592983B2 (OSRAM)
BE (1) BE904671A (OSRAM)
CA (1) CA1298836C (OSRAM)
CH (1) CH675722A5 (OSRAM)
CY (1) CY1641A (OSRAM)
DE (1) DE3614132A1 (OSRAM)
DK (3) DK164868C (OSRAM)
EG (1) EG18104A (OSRAM)
ES (3) ES8708229A1 (OSRAM)
FI (1) FI83316C (OSRAM)
FR (1) FR2581065B1 (OSRAM)
GB (1) GB2174987B (OSRAM)
GR (1) GR861086B (OSRAM)
HK (1) HK64492A (OSRAM)
HU (1) HU195813B (OSRAM)
IL (1) IL78581A0 (OSRAM)
IT (1) IT1215651B (OSRAM)
LU (1) LU86406A1 (OSRAM)
MY (1) MY102086A (OSRAM)
NL (1) NL8601053A (OSRAM)
NO (1) NO163406C (OSRAM)
NZ (1) NZ215885A (OSRAM)
OA (1) OA08242A (OSRAM)
PT (1) PT82460B (OSRAM)
SE (1) SE461468B (OSRAM)
SG (1) SG29092G (OSRAM)
SU (3) SU1450746A3 (OSRAM)
YU (1) YU46054B (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
EP0707585A1 (en) * 1993-07-06 1996-04-24 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6664264B2 (en) * 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
PH12006500401A1 (en) 2003-08-27 2005-03-10 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1673087B1 (en) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
WO2005048945A2 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2005284835A1 (en) * 2004-09-14 2006-03-23 Novartis Vaccines And Diagnostics Inc. Imidazoquinoline compounds
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
EP1863814A1 (en) 2005-04-01 2007-12-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
DK2583970T3 (en) 2006-08-02 2015-11-16 Cytokinetics Inc Certain chemical entities, compositions, and methods comprising imidazopyrimidines
WO2008121333A1 (en) 2007-03-30 2008-10-09 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
WO2013010015A2 (en) 2011-07-13 2013-01-17 Cytokinetics, Inc. Combination als therapy
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
GB2174987B (en) 1989-08-02
FI83316B (fi) 1991-03-15
DK164868C (da) 1993-01-11
DK80291D0 (da) 1991-04-30
AU592983B2 (en) 1990-02-01
NZ215885A (en) 1989-04-26
SE461468B (sv) 1990-02-19
DE3614132A1 (de) 1986-11-27
CA1298836C (en) 1992-04-14
NO163406C (no) 1990-05-23
YU116787A (en) 1988-04-30
FI83316C (fi) 1991-06-25
DK190986D0 (da) 1986-04-24
ES554336A0 (es) 1987-10-01
IT8620206A0 (it) 1986-04-24
FR2581065A1 (fr) 1986-10-31
AU5641386A (en) 1986-10-30
ES8802521A1 (es) 1988-07-16
CN1016175B (zh) 1992-04-08
HK64492A (en) 1992-09-04
NL8601053A (nl) 1986-11-17
ATA112186A (de) 1989-09-15
US4668686A (en) 1987-05-26
DK164868B (da) 1992-08-31
HUT42089A (en) 1987-06-29
BE904671A (fr) 1986-10-24
KR940000828B1 (ko) 1994-02-02
CH675722A5 (OSRAM) 1990-10-31
LU86406A1 (fr) 1986-11-05
FR2581065B1 (fr) 1990-02-02
DK80291A (da) 1991-04-30
DK165249B (da) 1992-10-26
SU1450746A3 (ru) 1989-01-07
ES8801829A1 (es) 1988-02-16
AT390257B (de) 1990-04-10
SU1560056A3 (ru) 1990-04-23
FI861684L (fi) 1986-10-26
DK165248B (da) 1992-10-26
GR861086B (en) 1986-09-01
PT82460A (en) 1986-05-01
EG18104A (en) 1992-09-30
IL78581A0 (en) 1986-08-31
CN86102747A (zh) 1987-02-04
SE8601907L (sv) 1986-10-26
CY1641A (en) 1992-11-06
SE8601907D0 (sv) 1986-04-24
DK165249C (da) 1993-03-22
KR860008177A (ko) 1986-11-12
ES557552A0 (es) 1988-07-16
SG29092G (en) 1992-05-15
SU1470192A3 (ru) 1989-03-30
GB2174987A (en) 1986-11-19
IT1215651B (it) 1990-02-22
YU46054B (sh) 1992-12-21
GB8610037D0 (en) 1986-05-29
NO861617L (no) 1986-10-27
FI861684A0 (fi) 1986-04-22
ES557551A0 (es) 1988-02-16
MY102086A (en) 1992-03-31
HU195813B (en) 1988-07-28
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
DK81091D0 (da) 1991-05-01
NO163406B (no) 1990-02-12
DK190986A (da) 1986-10-26
PT82460B (pt) 1988-11-30
OA08242A (en) 1987-10-30

Similar Documents

Publication Publication Date Title
ES8708229A1 (es) Un procedimiento para la obtencion de 1,3-dihidro-2h-imidazo (4,5-b)-quinolin-2-onas.
ES509242A0 (es) "procedimiento para preparar nuevos compuestos de cefem".
FI850140A0 (fi) Kemiska foereningar.
DE3369315D1 (en) Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
PH23448A (en) Quinoline compounds
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
SE8502525D0 (sv) 1,3-oxazolidine-2-one derivatives and processes for their preparation
ES2046229T3 (es) Composicion antiulcerosa.
ATE59844T1 (de) Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
DK160271C (da) Analogifremgangsmaade til fremstilling af 5-halogenvinyl-uracil-derivater
DE3267238D1 (de) Imidazo(1,2-a)quinoline derivatives
ES514235A0 (es) "procedimiento para la preparacion de acidos fenilalcohiloxirancarboxilicos".
ATE30323T1 (de) 5-phenylaethenylbenzimidazole.
ES8801264A1 (es) Procedimiento para la obtencion de derivados de piridazo(1,2-a)(1,2)diacepina
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
SU1179926A3 (ru) "cпocoб пoлучehия пpoизboдhыx cemиkapбaзидa или иx kиcлotho-aддиtиbhыx coлeй"
ATE36536T1 (de) Phosphoroimidate.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401